Current Challenges in Oncology Pharmacy

Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado. 

I mean, currently, obviously, it’s just going past the first the first fill, or even the first fill period, where we’ve been pretty much shut out from a lot of these commercial plans, so that’s been very frustrating. Because patients won’t always understand that, “I come here for my treatment but you can’t provide me with the medication I need for my cancer,” and that’s kind of a hard thing sometimes. So that’s definitely one thing. Payment reform is another thing. We’re part of the OCM project too, so getting some insight into that, and then all the different things that they’re doing in Congress currently right now. So those are some challenges that I see.

Most Popular

Related Articles

What considerations should pharmacists keep in mind when treating patients with chronic lymphocytic leukemia?
Bernard Marini, PharmD, BCOP, gives an overview of selecting the most effective, safest, and most cost-effective acute myeloid leukemia treatments for patients.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.